Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

42.62
-2.9100-6.39%
Post-market: 42.53-0.0900-0.21%19:58 EDT
Volume:5.71M
Turnover:246.17M
Market Cap:7.58B
PE:-30.23
High:45.07
Open:44.95
Low:42.19
Close:45.53
52wk High:104.32
52wk Low:36.22
Shares:177.91M
Float Shares:101.68M
Volume Ratio:1.29
T/O Rate:5.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4100
EPS(LYR):-1.4100
ROE:-89.48%
ROA:-9.66%
PB:15.43
PE(LYR):-30.23

Loading ...

Tempus AI Partners with Median Technologies to Integrate AI Lung Cancer Screening

Reuters
·
Feb 13

Tempus Announces Collaboration With Median Technologies to Integrate AI-Powered Lung Cancer Screening Into the Pixel Platform

THOMSON REUTERS
·
Feb 13

AI Software Shares Tumbled. AppLovin Down 16%; Unity Down 7%; BigBear.Ai, Roblox And Shopify Down 5%; Spotify, Tempus And SoundHound Down 4%

Tiger Newspress
·
Feb 12

AI Software Shares Tumbled. Unity Down 33%; Duolingo Down 6%; HubSpot, Figma, Shopify, SoundHound And GitLab Down 5%; Rubrik, AppLovin, C3.Ai And Datadog Down 4%

Tiger Newspress
·
Feb 11

Press Release: Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Dow Jones
·
Feb 10

AI Software Shares Kept Rally. Spotify And Datadog Up 10%; Shopify Up 5%; Unity, AppLovin And MongoDB Up 3%; Palantir And Cloudflare Up 2%

Tiger Newspress
·
Feb 10

24H | Some AI Software Shares Jump With AppLovin up over 4%, Shopify up over 3%; Silver Stocks & ETFs Fall With AGQ Down over 5%, SLV Down About 3%

Tiger Newspress
·
Feb 10

AI Application Shares Rebounded. Roblox And AppLovin Up 8%; Unity Up 6%; MongoDB Up 4%; Palantir And Shopify Up 2%

Tiger Newspress
·
Feb 09

Premarket Movers | Space Stocks Rally With Virgin Galactic up over 8%; AI Application Software Shares Gain With AppLovin up over 5%, Palantir up over 2%

Tiger Newspress
·
Feb 09

Tempus AI-Tochter Ambry Genetics unterstützt bahnbrechende Forschung zu Krebsgenen

Reuters
·
Feb 04

What's Going On With Tempus AI Stock Monday?

Benzinga_recent_news
·
Feb 02

Ambry Genetics Hits One Million RNA-Enhanced Genetic Tests Under Tempus AI

Reuters
·
Feb 02

Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares

Reuters
·
Jan 31

Assessing Tempus AI (TEM) Valuation After New Immune Profile Score Breakthrough

Simply Wall St.
·
Jan 30

Form 144 | Tempus AI's Officer Eric Lefkofsky proposes to sell 166,250 Shares, with a total value of approximately $11.1 Million.

Filings Track
·
Jan 29

Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits

MT Newswires Live
·
Jan 27

Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide

TIPRANKS
·
Jan 27

Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors

Benzinga_recent_news
·
Jan 27

Software Stocks Jump With Cloudflare up 10%

Tiger Newspress
·
Jan 26

Tempus AI Launches Paige Predict to Advance Digital Pathology

Reuters
·
Jan 21